ANEB: Anebulo Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 80.91
Enterprise Value ($M) 74.27
Book Value ($M) 6.49
Book Value / Share 0.25
Price / Book 12.47
NCAV ($M) 5.80
NCAV / Share 0.22
Price / NCAV 13.94

Profitability (mra)
Return on Invested Capital (ROIC) -1.62
Return on Assets (ROA) -0.73
Return on Equity (ROE) -0.81

Liquidity (mrq)
Quick Ratio 6.73
Current Ratio 6.73

Balance Sheet (mrq) ($M)
Current Assets 6.82
Assets 7.50
Liabilities 1.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-09-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 1 3,415 0.03
2024-05-02 2,235 8,472 26.38
2024-05-01 565 3,861 14.63
2024-04-30 15,375 1,758 874.57

(click for more detail)

Similar Companies
ALGS – Aligos Therapeutics, Inc. ALRN – Aileron Therapeutics, Inc.
ALZN – Alzamend Neuro, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited


Financial data and stock pages provided by
Fintel.io